Anbio Biotechnology Deferred Offering Costs
Anbio Biotechnology (NNNN) had Deferred Offering Costs of $387.44 thousand as of 2024-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-04-07
- 2024-12-31: Deferred Offering Costs $387.44K.
| Period end | Deferred Offering Costs |
|---|---|
| 2024-12-31 | $387.44K 20-F · filed 2026-04-07 |